Heterogeneous effect of calcium antagonists on leg oedema: A comparison of amlodipine versus lercanidipine in hypertensive patients

Journal of Hypertension

Volumn 21, Issue 10, 2003, Pages 1969-1973

  Pedrinelli, Roberto ^a   Dell'Omo, Giulia ^a   Nuti, Marco ^a   Menegato, Alessandra ^a   Balbarini, Alberto ^a   Mariani, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Amlodipine; Essential hypertension; Leg oedema; Lercanidipine; Skin blood flow

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; LERCANIDIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTOMATION; BLOOD PRESSURE MONITORING; BODY WEIGHT; CAPILLARY PRESSURE; CARDIOVASCULAR AUTOREGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CUTANEOUS PARAMETERS; DRUG EFFECT; EXTRAVASATION; FOOT; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; LASER DOPPLER FLOWMETRY; LEG EDEMA; MALE; OSCILLOMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN BLOOD FLOW; SUPINE POSITION; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 0142010505     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200310000-00026     Document Type: Article

References (30)

1. Opie LH. Calcium channel antagonists. Part IV: Side effects and contra-indications, interactions and combinations. Cardiovasc Drugs Ther 1988; 2:177-189.
2. Subramanian VB. Calcium antagonists in chronic stable angina pectoris. Amsterdam: Excerpta Medica; 1983, pp. 97-116, 152-156, 217-229.
3. Nilsson P, Lindholm LH, Hedner T. The Diltiazem Different Doses Study - a dose-response study of once-daily diltiazem therapy for hypertension. J Cardiovasc Pharmacol 1996; 27:469-475.
4. van Hamersvelt HW, Kloke HJ, de Jong DJ, Koene RA, Huysmans FT. Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention? J Hypertens 1996; 14:1041-1045.
5. Pedrinelli R, Dell'Omo G, Mariani M. Skin blood flow, dependent edema and calcium channel blockers. J Hum Hypertens 2001; 15:455-461.
6. Burges RA, Dodd MG, Gardiner DG. Pharmacologic profile of amlodipine. Am J Cardiol 1989; 64:101-181.
7. McClellan KJ, Jarvis B. Lercanidipine: a review of its use in hypertension. Drugs 2000; 60:1123-1140.
8. van Zwieten PA. The pharmacological properties of lipophilic calcium antagonists. Blood Press Suppl 1998; 2:5-9.
9. Fogari R, Malamani GD, Zoppi A, Preti P, Vanasia A, Fogari EW, Mugellini A. Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: a double blind, randomized, parallel study group. Curr Ther Res 2000; 61:850-862.
10. Leonetti G, Magnani B, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am J Hypertens 2002; 15: 932-940.
11. Lund-Johansen P, Stranden E, Helberg S, Wessel-Aas T, Risberg K, Ronnevik PK, et al. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens 2003; 21:1003-1010.
12. Henriksen O. Local sympathetic reflex mechanism in regulation of blood flow in human subcutaneous adipose tissue. Acta Physiol Scand Suppl 1977; 450:1-48.
13. Hassan AA, Tooke JE. Mechanism of the postural vasoconstrictor response in the human foot. Clin Sci (Colch) 1988; 75:379-387.
14. Prollet P, Meunier F, Lazareth I. Limb volume. Eur J Vasc Endovasc Surg 1997; 14:415-416.
15. Pedrinelli R, Dell'Omo G, Melillo E, Mariani M. Amlodipine, enalapril and dependent leg edema in hypertension. Hypertension 2000; 35:621-625.
16. Nilsson GE, Tenland T, Oberg PA. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng 1980; 27:597-604.
17. Grant RT, Bland EF. Observations on arteriovenous anastomoses in human skin and the bird's foot with special reference to the reaction to cold. Heart 1931; 15:385-407.
18. Hassan AA, Rayman G, Tooke JE. Effect of indirect heating on the postural control of skin blood flow in the human foot. Clin Sci (Colch) 1986; 70:577-582.
19. Iabichella ML, Dell'Omo G, Melillo E, Pedrinelli R. Calcium channel blockers blunt postural cutaneous vasoconstriction in hypertensive patients. Hypertension 1997; 29:751-756.
20. Henriksen O, Sejrsen P, Paaske WP, Eickhoff JH. Effect of chronic sympathetic denervation upon the transcapillary filtration rate induced by venous stasis. Acta Physiol Scand 1983; 117:171-176.
21. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999; 79:387-423.
22. Cesarone MR, Incandela L, Ledda A, De Sanctis MT, Steigerwalt R, Pellegrini L, et al. Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension. Angiology 2000; 51:S53-63.
23. Guyton AC. Capillary dynamics, and exchange of fluid between the blood and interstitial fluid. In: Textbook of medical physiology Philadelphia: WB Saunders; 1981, pp. 358-369.
24. Noddeland H, Aukland K, Nicolaysen G. Plasma colloid osmotic pressure in venous blood from the human foot in orthostasis. Acta Physiol Scand 1981; 113:447-454.
25. Michel CC, Curry FE. Microvascular permeability. Physiol Rev 1999; 79:703-761.
26. Arima S, Ito S, Omata K, Tsunoda K, Yaoita H, Abe K. Diverse effects of calcium antagonists on glomerular hemodynamics. Kidney Int Suppl 1996; 55:S132-S134.
27. Sabbatini M, Leonardi A, Testa R, Vitaioli L, Amenta F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000; 35:775-779.
28. Guazzi MD, De Cesare N, Galli C, Salvioni A, Tramontana C, Tamborini G, Bartorelli A. Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Circulation 1984; 70:279-284.
29. Abrams WB, Davies RO, Ferguson RK. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Fed Proc 1984; 43:1314-1321.
30. Zanchetti A, Omboni S, La Commare P, De Cesaris R, Palatini P. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol 2001; 38:642-650